Severe acute respiratory syndrome coronavirus 2
collected_by
ECU Health Medical Center
collection_date
2022-11-08
geo_loc_name
USA: North Carolina, Greenville
host
Homo sapiens
host_disease
B-cell acute lymphocyte leukemia
isolate
5
isolation_source
nasopharyngeal
antiviral_treatment_agent
dexamethasone
collection_device
swab
collection_method
nasopharyngeal swab
date_of_prior_antiviral_treat
2022-09-06
date_of_prior_sars_cov_2_infection
2022-09-06
date_of_sars_cov_2_vaccination
2021-09
host_age
17
host_disease_outcome
chronic
host_sex
male
passage_method
not applicable
passage_number
not applicable
prior_sars_cov_2_antiviral_treat
yes
prior_sars_cov_2_infection
yes
prior_sars_cov_2_vaccination
yes - partially completed
purpose_of_sampling
fever
purpose_of_sequencing
surveillance
sequenced_by
ECU BIG Core
sars_cov_2_diag_pcr_ct_value_1
32.5
virus_isolate_of_prior_infection
115239846
BioSampleModel
SARS-CoV-2: clinical or host-associated